{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,30]],"date-time":"2026-05-30T12:22:27Z","timestamp":1780143747868,"version":"3.54.0"},"reference-count":44,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2017,1,1]],"date-time":"2017-01-01T00:00:00Z","timestamp":1483228800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","gynecologiconcology-online.net","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Gynecologic Oncology"],"published-print":{"date-parts":[[2017,1]]},"DOI":"10.1016\/j.ygyno.2016.11.039","type":"journal-article","created":{"date-parts":[[2016,11,24]],"date-time":"2016-11-24T20:16:41Z","timestamp":1480018601000},"page":"5-7","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":15,"title":["Of mice and women - Non-ovarian origins of \u201covarian\u201d cancer"],"prefix":"10.1016","volume":"144","author":[{"given":"Anthony N.","family":"Karnezis","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kathleen R.","family":"Cho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ygyno.2016.11.039_bb0005","doi-asserted-by":"crossref","DOI":"10.1038\/nrc.2016.113","article-title":"The disparate origins of ovarian cancers: pathogenesis and prevention strategies","author":"Karnezis","year":"2016","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.ygyno.2016.11.039_bb0010","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1016\/j.ajpath.2015.11.011","article-title":"The dualistic model of ovarian carcinogenesis: revisited, revised, and expanded","volume":"186","author":"Kurman","year":"2016","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.ygyno.2016.11.039_bb0015","doi-asserted-by":"crossref","first-page":"R411","DOI":"10.1530\/ERC-16-0209","article-title":"Redefining the origin and evolution of ovarian cancer: a hormonal connection","volume":"23","author":"Cardenas","year":"2016","journal-title":"Endocr. Relat. Cancer"},{"key":"10.1016\/j.ygyno.2016.11.039_bb0020","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1158\/0008-5472.CAN-15-1382","article-title":"It's totally tubular\u2026riding the new wave of ovarian cancer research","volume":"76","author":"Perets","year":"2016","journal-title":"Cancer Res."},{"key":"10.1016\/j.ygyno.2016.11.039_bb0025","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1097\/PAP.0000000000000098","article-title":"The origin of epithelial neoplasms of the ovary: an alternative view","volume":"23","author":"Silva","year":"2016","journal-title":"Adv. Anat. Pathol."},{"issue":"Suppl. 8","key":"10.1016\/j.ygyno.2016.11.039_bb0030","doi-asserted-by":"crossref","first-page":"viii28","DOI":"10.1093\/annonc\/mdt308","article-title":"Coming into focus: the nonovarian origins of ovarian cancer","volume":"24","author":"Dubeau","year":"2013","journal-title":"Ann. Oncol."},{"key":"10.1016\/j.ygyno.2016.11.039_bb0035","doi-asserted-by":"crossref","first-page":"709","DOI":"10.2741\/S401","article-title":"The origin of ovarian cancers\u2014hypotheses and controversies","volume":"5","author":"Auersperg","year":"2013","journal-title":"Front. Biosci."},{"key":"10.1016\/j.ygyno.2016.11.039_bb0040","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s13669-011-0004-1","article-title":"Ovarian cancer is an imported disease: fact or fiction?","volume":"1","author":"Kuhn","year":"2012","journal-title":"Curr. Obstet. Gynaecol. Rep."},{"key":"10.1016\/j.ygyno.2016.11.039_bb0045","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1097\/01.pas.0000213335.40358.47","article-title":"Intraepithelial carcinoma of the fimbria and pelvic serous carcinoma: evidence for a causal relationship","volume":"31","author":"Kindelberger","year":"2007","journal-title":"Am. J. Surg. Pathol."},{"key":"10.1016\/j.ygyno.2016.11.039_bb0050","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1097\/GCO.0b013e328011a21f","article-title":"The distal fallopian tube: a new model for pelvic serous carcinogenesis","volume":"19","author":"Crum","year":"2007","journal-title":"Curr. Opin. Obstet. Gynecol."},{"key":"10.1016\/j.ygyno.2016.11.039_bb0055","article-title":"Support of the \u2018fallopian tube hypothesis\u2019 in a prospective series of risk-reducing salpingo-oophorectomy specimens","author":"Reitsma","year":"2012","journal-title":"Eur. J. Cancer"},{"key":"10.1016\/j.ygyno.2016.11.039_bb0060","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1038\/modpathol.2009.89","article-title":"Candidate serous cancer precursors in fallopian tube epithelium of BRCA1\/2 mutation carriers","volume":"22","author":"Shaw","year":"2009","journal-title":"Mod. Pathol."},{"key":"10.1016\/j.ygyno.2016.11.039_bb0065","doi-asserted-by":"crossref","first-page":"35","DOI":"10.3121\/cmr.2007.702","article-title":"Lessons from BRCA: the tubal fimbria emerges as an origin for pelvic serous cancer","volume":"5","author":"Crum","year":"2007","journal-title":"Clin. Med. Res."},{"key":"10.1016\/j.ygyno.2016.11.039_bb0070","doi-asserted-by":"crossref","first-page":"3985","DOI":"10.1200\/JCO.2007.12.2622","article-title":"Primary fallopian tube malignancies in BRCA-positive women undergoing surgery for ovarian cancer risk reduction","volume":"25","author":"Callahan","year":"2007","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.ygyno.2016.11.039_bb0075","doi-asserted-by":"crossref","first-page":"1222","DOI":"10.1097\/01.pas.0000202161.80739.ac","article-title":"Incidental carcinomas in prophylactic specimens in BRCA1 and BRCA2 germ-line mutation carriers, with emphasis on fallopian tube lesions: report of 6 cases and review of the literature","volume":"30","author":"Carcangiu","year":"2006","journal-title":"Am. J. Surg. Pathol."},{"key":"10.1016\/j.ygyno.2016.11.039_bb0080","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1002\/path.1000","article-title":"Dysplastic changes in prophylactically removed Fallopian tubes of women predisposed to developing ovarian cancer","volume":"195","author":"Piek","year":"2001","journal-title":"J. Pathol."},{"key":"10.1016\/j.ygyno.2016.11.039_bb0085","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1097\/PAS.0b013e3181ef7b16","article-title":"Are all pelvic (nonuterine) serous carcinomas of tubal origin?","volume":"34","author":"Przybycin","year":"2010","journal-title":"Am. J. Surg. Pathol."},{"key":"10.1016\/j.ygyno.2016.11.039_bb0090","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1097\/PAS.0000000000000353","article-title":"Incidental nonuterine high-grade serous carcinomas arise in the fallopian tube in most cases: further evidence for the tubal origin of high-grade serous carcinomas","volume":"39","author":"Gilks","year":"2015","journal-title":"Am. J. Surg. Pathol."},{"key":"10.1016\/j.ygyno.2016.11.039_bb0095","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1097\/PAS.0000000000000352","article-title":"Incidental serous tubal intraepithelial carcinoma and early invasive serous carcinoma in the nonprophylactic setting: analysis of a case series","volume":"39","author":"Morrison","year":"2015","journal-title":"Am. J. Surg. Pathol."},{"key":"10.1016\/j.ygyno.2016.11.039_bb0100","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1097\/PAS.0000000000000199","article-title":"Early detection of high-grade tubal serous carcinoma in women at low risk for hereditary breast and ovarian cancer syndrome by systematic examination of fallopian tubes incidentally removed during benign surgery","volume":"38","author":"Rabban","year":"2014","journal-title":"Am. J. Surg. Pathol."},{"key":"10.1016\/j.ygyno.2016.11.039_bb0105","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.ygyno.2015.10.022","article-title":"Primary site assignment in tubo-ovarian high-grade serous carcinoma: consensus statement on unifying practice worldwide","volume":"141","author":"Singh","year":"2016","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.ygyno.2016.11.039_bb0110","doi-asserted-by":"crossref","DOI":"10.1001\/jamaoncol.2015.1618","article-title":"Next-generation sequencing of tubal intraepithelial carcinomas","author":"McDaniel","year":"2015","journal-title":"JAMA Oncol."},{"key":"10.1016\/j.ygyno.2016.11.039_bb0115","doi-asserted-by":"crossref","DOI":"10.1097\/PAS.0000000000000757","article-title":"Uterine serous carcinomas frequently metastasize to the fallopian tube and can mimic serous tubal intraepithelial carcinoma","author":"Kommoss","year":"2016","journal-title":"Am. J. Surg. Pathol."},{"key":"10.1016\/j.ygyno.2016.11.039_bb0120","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1097\/PAS.0000000000000293","article-title":"Nongynecologic metastases to fallopian tube mucosa: a potential mimic of tubal high-grade serous carcinoma and benign tubal mucinous metaplasia or nonmucinous hyperplasia","volume":"39","author":"Rabban","year":"2015","journal-title":"Am. J. Surg. Pathol."},{"key":"10.1016\/j.ygyno.2016.11.039_bb0125","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1097\/PGP.0000000000000206","article-title":"Secondary involvement of the adnexa and uterine corpus by carcinomas of the uterine cervix: a detailed morphologic description","volume":"34","author":"Reyes","year":"2015","journal-title":"Int. J. Gynecol. Pathol."},{"key":"10.1016\/j.ygyno.2016.11.039_bb0130","doi-asserted-by":"crossref","first-page":"E106","DOI":"10.1111\/j.1365-2559.2012.04194.x","article-title":"Fallopian tube metastases of non-gynaecological origin: a series of 20 cases emphasizing patterns of involvement including intra-epithelial spread","volume":"60","author":"Stewart","year":"2012","journal-title":"Histopathology"},{"key":"10.1016\/j.ygyno.2016.11.039_bb0135","first-page":"385","article-title":"Implantation carcinoma of the tubal mucosa secondary to carcinoma of the ovary","volume":"14","author":"Sampson","year":"1938","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.ygyno.2016.11.039_bb0140","doi-asserted-by":"crossref","first-page":"5367","DOI":"10.3390\/ijms14035367","article-title":"Endometriosis-associated ovarian cancer: a review of pathogenesis","volume":"14","author":"Worley","year":"2013","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ygyno.2016.11.039_bb0145","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1097\/00000478-198203000-00003","article-title":"Endosalpingiosis in the omentum: a study of autopsy and surgical material","volume":"6","author":"Zinsser","year":"1982","journal-title":"Am. J. Surg. Pathol."},{"key":"10.1016\/j.ygyno.2016.11.039_bb0150","series-title":"Blaustein's Pathology of the Female Genital Tract","article-title":"Diseases of the peritoneum","author":"Irving","year":"2011"},{"key":"10.1016\/j.ygyno.2016.11.039_bb0155","first-page":"61","article-title":"Biomarkers and endosalpingiosis in the ovarian and tubal microenvironment of women at high-risk for pelvic serous carcinoma","volume":"4","author":"Gruessner","year":"2014","journal-title":"Am. J. Cancer Res."},{"key":"10.1016\/j.ygyno.2016.11.039_bb0160","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1038\/modpathol.2013.107","article-title":"Ovarian and endometrial endometrioid carcinomas have distinct CTNNB1 and PTEN mutation profiles","volume":"27","author":"McConechy","year":"2014","journal-title":"Mod. Pathol."},{"key":"10.1016\/j.ygyno.2016.11.039_bb0165","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1016\/j.ygyno.2011.01.005","article-title":"Clear cell carcinoma of the ovary: a report from the first Ovarian Clear Cell Symposium, June 24th, 2010","volume":"121","author":"Anglesio","year":"2011","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.ygyno.2016.11.039_bb0170","doi-asserted-by":"crossref","first-page":"1532","DOI":"10.1056\/NEJMoa1008433","article-title":"ARID1A mutations in endometriosis-associated ovarian carcinomas","volume":"363","author":"Wiegand","year":"2010","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ygyno.2016.11.039_bb0175","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1126\/science.1196333","article-title":"Frequent mutations of chromatin remodeling gene ARID1A in ovarian clear cell carcinoma","volume":"330","author":"Jones","year":"2010","journal-title":"Science"},{"key":"10.1016\/j.ygyno.2016.11.039_bb0180","doi-asserted-by":"crossref","first-page":"1597","DOI":"10.2353\/ajpath.2009.081000","article-title":"Frequent activating mutations of PIK3CA in ovarian clear cell carcinoma","volume":"174","author":"Kuo","year":"2009","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.ygyno.2016.11.039_bb0185","series-title":"Ovarian Cancers: Evolving Paradigms in Research and Care","author":"Committee on the State of the Science in Ovarian Cancer Research BoHCS","year":"2016"},{"key":"10.1016\/j.ygyno.2016.11.039_bb0190","doi-asserted-by":"crossref","first-page":"4141","DOI":"10.1158\/0008-5472.CAN-11-3834","article-title":"Perturbation of Rb, p53, and Brca1 or Brca2 cooperate in inducing metastatic serous epithelial ovarian cancer","volume":"72","author":"Szabova","year":"2012","journal-title":"Cancer Res."},{"key":"10.1016\/j.ygyno.2016.11.039_bb0195","doi-asserted-by":"crossref","first-page":"6118","DOI":"10.1038\/ncomms7118","article-title":"Coexistent ARID1A\u2013PIK3CA mutations promote ovarian clear-cell tumorigenesis through pro-tumorigenic inflammatory cytokine signalling","volume":"6","author":"Chandler","year":"2015","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ygyno.2016.11.039_bb0200","first-page":"en20141977","article-title":"The ovary is an alternative site of origin for high-grade serous ovarian cancer in mice","author":"Kim","year":"2015","journal-title":"Endocrinology"},{"key":"10.1016\/j.ygyno.2016.11.039_bb0205","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1016\/j.ccr.2013.10.013","article-title":"Transformation of the fallopian tube secretory epithelium leads to high-grade serous ovarian cancer in Brca;Tp53;Pten models","volume":"24","author":"Perets","year":"2013","journal-title":"Cancer Cell"},{"key":"10.1016\/j.ygyno.2016.11.039_bb0210","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.1117135109","article-title":"High-grade serous ovarian cancer arises from fallopian tube in a mouse model","author":"Kim","year":"2012","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.ygyno.2016.11.039_bb0215","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/j.ccr.2007.02.016","article-title":"Mouse model of human ovarian endometrioid adenocarcinoma based on somatic defects in the Wnt\/\u03b2-catenin and PI3K\/Pten signaling pathways","volume":"11","author":"Wu","year":"2007","journal-title":"Cancer Cell"},{"key":"10.1016\/j.ygyno.2016.11.039_bb0220","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1002\/path.4783","article-title":"Impact of oviductal versus ovarian epithelial cell of origin on ovarian endometrioid carcinoma phenotype in the mouse","volume":"240","author":"Wu","year":"2016","journal-title":"J. Pathol."}],"container-title":["Gynecologic Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090825816316080?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090825816316080?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,9,27]],"date-time":"2020-09-27T13:54:33Z","timestamp":1601214873000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0090825816316080"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,1]]},"references-count":44,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2017,1]]}},"alternative-id":["S0090825816316080"],"URL":"https:\/\/doi.org\/10.1016\/j.ygyno.2016.11.039","relation":{},"ISSN":["0090-8258"],"issn-type":[{"value":"0090-8258","type":"print"}],"subject":[],"published":{"date-parts":[[2017,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Of mice and women - Non-ovarian origins of \u201covarian\u201d cancer","name":"articletitle","label":"Article Title"},{"value":"Gynecologic Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ygyno.2016.11.039","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}